Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
Nuclear medicine and biology • Vol. 38, Issue 2 • 2011
Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects.
Nuclear medicine and biology • Vol. 36, Issue 5 • 2009
Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals.
Journal of pharmaceutical sciences • Vol. 98, Issue 6 • 2009